Cancer Genetics, Inc. announces pricing of public offering of common stock
Cancer Genetics announced pricing of an underwritten public offering of 13,333,334 shares of its common stock at a price to the public of $0.225 per share. Cancer Genetics granted underwriter a 45-day option to purchase up to an additional 2,000,000 shares of its common stock. January 10, 2019